| Insurance Industry | Financials Sector | Dr. Irit Yaniv M.D. CEO | TASE Exchange | - ISIN |
| Il Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Almeda Ventures Limited Partnership is a trailblazing venture capital firm, established in 2020 and headquartered in Tel Aviv, Israel. Carving out a niche in the investment landscape, Almeda Ventures is dedicated to nurturing innovative companies at the seed, startup, early venture, and middle market stages. The firm is distinguished by its strategic focus on health technology, leveraging public R&D partnerships, and prioritizing investments that promise to revolutionize the medical and life sciences fields. Its geographical scope spans Israel, the USA, and Europe, aiming to foster a global impact through cutting-edge technological advancements.
Almeda Ventures identifies and invests in promising health technology initiatives that benefit from public research and development partnerships. This approach enables the firm to support technologies that have access to public funding, resources, and expertise, enhancing their likelihood for success and innovation.
Investing in the development and commercialization of medical devices is a core focus area for Almeda Ventures. The firm scouts for cutting-edge medical devices that promise to improve patient care, with a keen interest in innovations that offer novel solutions to existing health challenges.
The firm is proactive in seeking out digital health solutions that leverage technology to enhance healthcare delivery. This encompasses a wide range of technologies, including telehealth, health information technologies, and wearable devices, all aimed at improving healthcare outcomes and efficiency.
Almeda Ventures places a significant emphasis on bio-convergence, an innovative field at the intersection of biology with engineering, computational science, and other disciplines. The firm invests in companies that are pioneering this cross-disciplinary approach to address complex health challenges.
Supporting life sciences research and development is another pillar of Almeda Ventures' investment strategy. The firm backs companies engaged in groundbreaking R&D with the potential to yield transformative discoveries and therapeutic solutions in health and medicine.